MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Two Regulatory Consultancy Firms Plan to Become One

Brandwood Biomedical and Capital K Consulting plan to merge in July to form Brandwood-CKC.

Brandwood Biomedical and Capital K Consulting plan to merge into one consultancy firm as of July 1 to form Brandwood-CKC. 

Brandwood is based in St. Leonards, Sydney, Australia and provides international regulatory, reimbursement, and product development consultancy for medical devices and in vitro diagnostics. Capital K Consulting, based in Pennant Hills, New South Wales, Australia, provides regulatory services for corporations with Australia and New Zealand prescription and over-the-counter pharmaceuticals.

The combined firm will be based in St. Leonards, Sydney and also will have offices in Los Angeles, CA; Wellington, Australia; Beijing, China; Taipei, Taiwan; Hong Kong, Japan; and Hyderabad, Telangana, India.

“This merger will bring together two leading expert technical consulting firms to offer comprehensive pre-launch services in an era of increasingly complex technologies which intersect and reinvent medicines, devices and diagnostics, hardware and software to produce innovative new life science products," said Robert Stringer, managing director at Capital K Consulting.

Brandwood-CKC will offer regulatory, reimbursement, quality systems, technical, and regulatory appeal services addressing Australia, New Zealand, and the broader Asia-Pacific, North America, and European markets. Financial terms of the deal were not disclosed.

“We have always taken a global view, with a deep engagement in the process of international harmonization of regulation. This merger is a natural progression towards a truly integrated service offering across all areas of therapeutics and diagnostics in global markets” said Arthur Brandwood, founder and principal consultant at Brandwood Biomedical.

The expanded business will support a client base of more than 100 leading providers of therapeutics, ranging from startups to multinationals.

“This merger of two very well-respected firms in the industry brings technical strength and diversity, coupled with an integrated commercial focus, making Brandwood-CKC the premier regulatory partner for any local or international healthcare product corporation," said Grant Bennett, who will serve as the inaugural CEO at Brandwood-CKC.

500 characters remaining